A Pilot Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Estrogen and/or Progesterone Receptor Positive Breast Cancer

被引：0
|
作者：
Forero, A. [1 ]
Saleh, M. [1 ]
Galleshaw, J. [1 ]
Jones, C. [1 ]
Shah, J. [1 ]
Percent, I [1 ]
Nabell, L. [1 ]
Carpenter, J. [1 ]
Falkson, C. [1 ]
Krontiras, H. [1 ]
Urist, M. [1 ]
Bland, K. [1 ]
De Los Santos, J. [1 ]
Meredith, R. [1 ]
Caterinicchia, V [1 ]
Bernreuter, W. [1 ]
O'Malley, J. [1 ]
Li, Y. [1 ]
LoBuglio, A. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：567S / 567S
页数：1
相关论文
共 50 条
  • [1] Long Term Follow-Up of a Pilot Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Estrogen and/or Progesterone Receptor Positive Breast Cancer
    Forero, A.
    Saleh, M.
    Galleshaw, J.
    Jones, C.
    Nabell, L.
    Carpenter, J.
    Falkson, C.
    Krontiras, H.
    Urist, M.
    Bland, K.
    De Los Santos, J.
    Meredith, R.
    Caterinicchia, V.
    Bernreuter, W.
    O'Malley, J.
    Yufeng, L.
    LoBuglio, A.
    CANCER RESEARCH, 2010, 70
  • [2] A study of pre-operative (neoadjuvant) letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed operable breast cancer: A preliminary safety report
    Forero-Torres, A.
    Percent, I.
    Galleshaw, J.
    Nabell, L.
    Carpenter, J.
    Falkson, C.
    Jones, C.
    Krontriras, H.
    De Los Santos, J.
    Saleh, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A study of pre-operative letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed operable breast cancer: A preliminary safety report
    Percent, I. J.
    Forero, A.
    Galleshaw, J.
    Nabel, L.
    Carpenter, J.
    Falkson, C.
    Jones, C.
    Krontriras, H.
    Saleh, M.
    Santos, J. De Los
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 469 - 469
  • [4] Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor-or Progesterone Receptor-Positive Breast Cancer
    Forero-Torres, Andres
    Saleh, Mansoor N.
    Galleshaw, Janice A.
    Jones, Cheryl F.
    Shah, Jatin J.
    Percent, Ivor J.
    Nabell, Lisle M.
    Carpenter, John T.
    Falkson, Carla I.
    Krontiras, Helen
    Urist, Marshall M.
    Bland, Kirby I.
    De Los Santos, Jennifer F.
    Meredith, Ruby F.
    Caterinicchia, Valerie
    Bernreuter, Wanda K.
    O'Malley, Janis P.
    Li, Yufeng
    LoBuglio, Albert F.
    CLINICAL BREAST CANCER, 2010, 10 (04) : 275 - 280
  • [5] Long term follow-up of the neo-adjuvant pilot trial evaluating activity of letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed estrogen and/or progesterone receptor positive primary breast cancer
    Forero, A.
    Delos Santos, J.
    Bowen, K.
    Jones, C.
    Varley, K. E.
    Nabell, L.
    Carpenter, J. T.
    Falkson, C. I.
    Krontiras, H.
    Caterinicchia, V.
    O'Malley, J.
    Li, Y.
    LoBuglio, A. F.
    Myers, R.
    Saleh, M. N.
    CANCER RESEARCH, 2013, 73
  • [6] PIONEER: pre-operative window study of letrozole plus progesterone receptor agonist megestrol acetate versus letrozole alone in post-menopausal patients with oestrogen receptor-positive breast cancer
    Burrell, Rebecca A.
    Kumar, Sanjeev S.
    Kateb, Angels
    Dougall, Greig
    Wulff, Jerome
    Benson, John
    Forouhi, Parto
    Agrawal, Amit
    McIntosh, Stuart
    King, Polly
    Raytor, Zenon
    Sweetland, Helen
    Pitsinis, Vassilis
    Hadad, Sirwan
    Hamed, Hisham
    Schmid, Peter
    Caldas, Carlos
    Pantziarka, Pan
    Provenzano, Elena
    Carroll, Jason S.
    Baird, Richard D.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 542 - 542
  • [7] A pilot open-label trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed operable breast cancer
    Forero-Torres, A.
    Galleshaw, J.
    Jones, C.
    Percent, I.
    Nabell, L.
    Carpenter, J.
    Falkson, C.
    Krontiras, H.
    Bland, K.
    De Los Santos, J.
    Saleh, M. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] TBCRC 002: A phase II, randomized, open label trial of preoperative letrozole versus letrozole (LET) in combination with bevacizumab (BEV) in post-menopausal women with newly diagnosed stage II/III breast cancer
    Forero-Torres, Andres
    Rugo, Hope S.
    Vaklavas, Christos
    Lin, Nancy U.
    Carey, Lisa A.
    Liu, Minetta C.
    Nanda, Rita
    Puhalla, Shannon
    Storniolo, Anna Maria
    Krontiras, Helen
    Saleh, Mansoor N.
    Li, Yufeng
    LoBuglio, Albert F.
    De Los Santos, Jennifer F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Neoadjuvant hormonal therapy is associated with comparable outcomes to neoadjuvant chemotherapy in post-menopausal women with estrogen receptor-positive breast cancer
    Marcus, David M.
    Switchenko, Jeffrey M.
    Prabhu, Roshan
    O'Regan, Ruth
    Zelnak, Amelia
    Fasola, Carolina
    Mister, Donna
    Torres, Mylin A.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [10] The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer
    Isnaldi, Edoardo
    Richard, Francois
    De Schepper, Maxim
    Leduc, Sophia
    Maetens, Marion
    Geukens, Tatjana
    Van Baelen, Karen
    Nguyen, Ha-Linh
    Rouas, Ghizlane
    Zoppoli, Gabriele
    Cardoso, Fatima
    Sotiriou, Christos
    Larsimont, Denis
    Floris, Giuseppe
    Biganzoli, Elia
    Desmedt, Christine
    NPJ BREAST CANCER, 2022, 8 (01)
12345